- Report
- April 2025
- 298 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 149 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 93 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 258 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 194 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 179 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 183 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 196 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 182 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 154 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 307 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 178 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 196 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 270 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 386 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 282 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 361 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 286 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 383 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 274 Pages
Global
From €5324EUR$5,850USD£4,522GBP

Retinopathy is a medical condition that affects the retina, the light-sensitive tissue at the back of the eye. It is a leading cause of blindness and visual impairment worldwide. Optical treatments for retinopathy include laser photocoagulation, intravitreal injections, and vitrectomy. Laser photocoagulation is used to reduce the risk of vision loss by sealing off leaking blood vessels in the retina. Intravitreal injections are used to deliver medications directly to the retina to reduce swelling and inflammation. Vitrectomy is a surgical procedure used to remove scar tissue and other debris from the vitreous cavity.
Companies in the retinopathy market include Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Heidelberg Engineering, Nidek, Optos, Topcon, and Zeiss. Show Less Read more